Reply to the comment "Effect of Infliximab on Male Fertility" by Younis et al.
Rheumatology Clinic, Department of Internal Medicine, Medical School, University of Ioannina, Ioannina 45110, Greece.
Theodora E
TE
Markatseli
Rheumatology Clinic, Department of Internal Medicine, Medical School, University of Ioannina, Ioannina 45110, Greece.
Charalampos
C
Papagoras
Rheumatology Clinic, Department of Internal Medicine, Medical School, University of Ioannina, Ioannina 45110, Greece.
Evripidis
E
Kaltsonoudis
Rheumatology Clinic, Department of Internal Medicine, Medical School, University of Ioannina, Ioannina 45110, Greece.
Paraskevi V
PV
Voulgari
Rheumatology Clinic, Department of Internal Medicine, Medical School, University of Ioannina, Ioannina 45110, Greece. Electronic address: adrosos@cc.uoi.gr.
Alexandros A
AA
Drosos
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D006801:Humans; D007248:Infertility, Male / Q000139:chemically induced*; D008297:Male; D025242:Spondylarthropathies / Q000188:drug therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha
Anti-TNFα therapy; Infliximab; Male fertility; Spondyloarthropathies